Obstetrics & Gynecology Email Alerts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 1999;93:707-711
© 1999 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BENN, P. A.
Right arrow Articles by HORNE, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BENN, P. A.
Right arrow Articles by HORNE, D.

ORIGINAL RESEARCH

Maternal Serum Screening for Fetal Trisomy 18: A Comparison of Fixed Cutoff and Patient-Specific Risk Protocols

PETER A. BENN, PhD, MAURO V. LEO, MD, JOHN F. RODIS, MD, TRYFON BEAZOGLOU, PhD, ROXANNE COLLINS and DONNA HORNE

From the Division of Human Genetics, Department of Pediatrics; Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology; and the Department of Pediatric Dentistry, University of Connecticut Health Center, Farmington, Connecticut.

Address reprint requests to: Peter Benn, PhD University of Connecticut Health Center Division of Human Genetics 263 Farmington Avenue Farmington, CT 06030-6140 E-mail: benn{at}nso1.uchc.edu.

Objective: To compare the effectiveness of two widely used protocols for second-trimester screening for fetal trisomy 18.

Methods: Second-trimester screening results for 41,565 women were reviewed to determine whether pregnancies could be considered to be at high risk for trisomy 18. The screening test was considered positive if either maternal serum concentrations of alpha-fetoprotein (MSAFP), hCG, and unconjugated estriol (E3) fell below defined levels, or the second-trimester patient-specific risk (based on maternal age and serum analytes) was greater than 1:100. Detection rates, false-positive rates, and pregnancy outcomes for the two protocols were compared.

Results: The fixed-cutoff method showed a 23% detection rate and a 0.19% false-positive rate for trisomy 18. These low rates were in close agreement with a theoretical expectation for fixed-cutoff trisomy 18 screening. The risk-based approach resulted in a 69% detection rate and a 0.45% false-positive rate. Both methods identified pregnancies with other fetal anomalies.

Conclusion: Overall, the risk-based method is more effective than the fixed-cutoff approach to trisomy 18 screening.




This article has been cited by other articles:


Home page
Obstet GynecolHome page
F. M. Breathnach, F. D. Malone, G. Lambert-Messerlian, H. S. Cuckle, T. F. Porter, D. A. Nyberg, C. H. Comstock, G. R. Saade, R. L. Berkowitz, S. Klugman, et al.
First- and Second-Trimester Screening: Detection of Aneuploidies Other Than Down Syndrome
Obstet. Gynecol., September 1, 2007; 110(3): 651 - 657.
[Abstract] [Full Text] [PDF]


Home page
Obstet GynecolHome page
J. F. X. EGAN, P. BENN, A. F. BORGIDA, J. F. RODIS, W. A. CAMPBELL, and A. M. VINTZILEOS
Efficacy of Screening for Fetal Down Syndrome in the United States From 1974 to 1997
Obstet. Gynecol., December 1, 2000; 96(6): 979 - 985.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Obstetricians and Gynecologists.